{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:45:06Z","timestamp":1764193506248},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1054\/jocn.1999.0194","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:35:14Z","timestamp":1027683314000},"page":"191-194","source":"Crossref","is-referenced-by-count":12,"title":["Anti-GM1 ganglioside antibodies: their role in the diagnosis and pathogenesis of immune-mediated motor neuropathies"],"prefix":"10.1054","volume":"7","author":[{"given":"Andrew J","family":"Kornberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/jocn.1999.0194_RF1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410300312","article-title":"Immunosuppressive treatment in multifocal motor neuropathy","volume":"30","author":"Feldman","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF3","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1212\/WNL.44.11.2028","article-title":"Distal lower motor neuron syndrome with high titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide","volume":"44","author":"Pestronk","year":"1994","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.42.3.506","article-title":"Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy","volume":"42","author":"Kaji","year":"1992","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.410330303","article-title":"Multifocal motor neuropathy: response to human immune globulin","volume":"33","author":"Chaudhry","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.43.3_Part_1.537","article-title":"High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy","volume":"43","author":"Nobile-Orazio","year":"1993","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/ana.410370706","article-title":"Chronic motor neuropathies: diagnosis, therapy, and pathogenesis","volume":"37(S1)","author":"Kornberg","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410270314","article-title":"Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies","volume":"27","author":"Pestronk","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mus.880170115","article-title":"The clinical and diagnostic role of anti-GM1 antibody testing","volume":"17","author":"Kornberg","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF10","article-title":"Results of testing for anti-GM1 antibodies","author":"McCombe","year":"1999","journal-title":"J Clin Neurosci"},{"key":"10.1054\/jocn.1999.0194_RF11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mus.880141002","article-title":"Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies","volume":"14","author":"Pestronk","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/WNL.40.7.1067","article-title":"The spectrum of neurologic disease associated with anti-GM1 antibodies","volume":"40","author":"Sadiq","year":"1990","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-5728(91)90192-A","article-title":"Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera","volume":"32","author":"Adams","year":"1991","journal-title":"J Neuroimmunol"},{"key":"10.1054\/jocn.1999.0194_RF14","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1086\/513800","article-title":"Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome","volume":"176(Suppl 2)","author":"Yuki","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1054\/jocn.1999.0194_RF15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/brain\/122.5.797","article-title":"Facts and fallacies on anti-GM1 antibodies: physiology of motor neuropathies","volume":"122","author":"Kaji","year":"1999","journal-title":"Brain"},{"key":"10.1054\/jocn.1999.0194_RF16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-5728(89)90144-6","article-title":"Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, USA","volume":"25","author":"Marcus","year":"1989","journal-title":"J Neuroimmunol"},{"key":"10.1054\/jocn.1999.0194_RF17","first-page":"1491","article-title":"The clinical correlates of IgG antiganglioside antibodies (a reply)","volume":"18","author":"Pestronk","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-510X(91)90312-U","article-title":"Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders","volume":"104","author":"Li","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1054\/jocn.1999.0194_RF19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/WNL.38.9.1457","article-title":"Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis","volume":"38","author":"Pestronk","year":"1988","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ana.410250118","article-title":"Patterns of serum IgM antibodies to GM1 and GD1 a gangliosides in amyotrophic lateral sclerosis","volume":"25","author":"Pestronk","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0889-857X(21)00735-3","article-title":"Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes","volume":"18","author":"Monestier","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1054\/jocn.1999.0194_RF22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1212\/WNL.44.6.1131","article-title":"Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation","volume":"44","author":"Pestronk","year":"1994","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.48.4.1104","article-title":"Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone","volume":"48","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1212\/WNL.49.5.1289","article-title":"Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates","volume":"49","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.410350217","article-title":"The clinical correlates of high titer IgG anti-GM1 antibodies","volume":"35","author":"Kornberg","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1212\/WNL.47.5.1317","article-title":"Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes","volume":"47","author":"Kornberg","year":"1996","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ 1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.43.2.414","article-title":"Frequent presence of anti-GQ1bantibody in Fisher\u2019s syndrome","volume":"43","author":"Yuki","year":"1993","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ana.410440610","article-title":"Neuromuscular blockade by IgG antibodies from patients with Guillain-Barr\u00e9 syndrome: a macro-patch-clamp study","volume":"44","author":"Buchwald","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-510X(97)00103-2","article-title":"IgM anti-sulfatide autoantibodies: patterns of binding to cerebellum, dorsal root ganglion and peripheral nerve","volume":"151","author":"Lopate","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1054\/jocn.1999.0194_RF31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.41.3.357","article-title":"Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein","volume":"41","author":"Pestronk","year":"1991","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF32","article-title":"Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation","volume":"44(Suppl 2)","author":"Pestronk","year":"1994","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F","article-title":"Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical\/electrophysiological features in 40 cases","volume":"21","author":"Chassande","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF34","article-title":"Anti-MAG and anti-sulfatide antibodies: variability in tissue staining patterns and correlation with ELISA binding to non-hydroxylated sulfatide","volume":"Supplement 7","author":"Lopate","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF35","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199805283382207","article-title":"Neuropathies associated with paraproteinemia","volume":"338","author":"Ropper","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/jocn.1999.0194_RF36","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1212\/WNL.44.12.2395","article-title":"Acute ataxic neuropathy with cross-reactive antibodies to GD1band GD3gangliosides","volume":"44","author":"Willison","year":"1994","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.410390402","article-title":"Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?","volume":"39","author":"Dalakas","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF38","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<840::AID-MUS8>3.0.CO;2-7","article-title":"Binding of antibodies against GM1 and GD1b in human peripheral nerve","volume":"20","author":"Kusunoki","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1212\/WNL.36.4.454","article-title":"Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease","volume":"36","author":"Freddo","year":"1986","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-5728(93)90239-U","article-title":"Gangliosides and bacterial toxins in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Willison","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1054\/jocn.1999.0194_RF41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410280312","article-title":"IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block","volume":"28","author":"Santoro","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/WNL.43.4.809","article-title":"Localization of GM1 and Gal(b1\u20133)GalNAc antigenic determinants in peripheral nerve","volume":"43","author":"Corbo","year":"1993","journal-title":"Neurology"},{"key":"10.1054\/jocn.1999.0194_RF43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ana.410320402","article-title":"Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons","volume":"32","author":"Corbo","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mus.880170116","article-title":"Do GM1 antibodies induce demyelination?","volume":"17","author":"Lange","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF45","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mus.880160606","article-title":"Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies","volume":"16","author":"Uncini","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF46","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/ana.410270711","article-title":"Neuropathy and anti-GM1 antibodies","volume":"27(suppl)","author":"Latov","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00005072-199003000-00001","article-title":"Human monoclonal IgM anti-Gal(b1\u20133) GalNAc autoantibodies bind to the surface of bovine spinal motoneurons","volume":"49","author":"Thomas","year":"1990","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1054\/jocn.1999.0194_RF48","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00296548","article-title":"Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier","volume":"82","author":"Thomas","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1054\/jocn.1999.0194_RF49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-5728(89)90131-8","article-title":"Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy","volume":"25","author":"Baba","year":"1989","journal-title":"J Neuroimmunol"},{"key":"10.1054\/jocn.1999.0194_RF50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mus.880160603","article-title":"Acute conduction block in vitro following exposure to antiganglioside sera","volume":"16","author":"Arasaki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1054\/jocn.1999.0194_RF51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410350416","article-title":"Cloning of human anti-GM1 antibodies from motor neuropathy patients","volume":"35","author":"Willison","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF52","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1471-4159.1990.tb04930.x","article-title":"Different ceramide compositions of gangliosides between human motor and sensory nerves","volume":"55","author":"Ogawa-Goto","year":"1990","journal-title":"J Neurochem"},{"key":"10.1054\/jocn.1999.0194_RF53","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1471-4159.1992.tb11018.x","article-title":"Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina","volume":"59","author":"Ogawa-Goto","year":"1992","journal-title":"J Neurochem"},{"key":"10.1054\/jocn.1999.0194_RF54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.410330202","article-title":"Molecular dissection of the myelinated axon","volume":"33","author":"Waxman","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.410370403","article-title":"Sodium channel blockade by antibodies: a new mechanism of neurological disease?","volume":"37","author":"Waxman","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF56","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.410370405","article-title":"Antibodies against GM1ganglioside affect K+and Na+currents in isolated rat myelinated nerve fibers","volume":"37","author":"Takigawa","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1054\/jocn.1999.0194_RF57","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/120.12.2159","article-title":"The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons","volume":"120","author":"Hirota","year":"1997","journal-title":"Brain"},{"key":"10.1054\/jocn.1999.0194_RF58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/brain\/122.3.449","article-title":"The distribution of ganglioside-like moieties in peripheral nerve","volume":"122","author":"Sheikh","year":"1999","journal-title":"Brain"},{"key":"10.1054\/jocn.1999.0194_RF59","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/122.5.807","article-title":"Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro","volume":"122","author":"Paparounas","year":"1999","journal-title":"Brain"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586899901947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586899901947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:46:54Z","timestamp":1682142414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586899901947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0967586899901947"],"URL":"https:\/\/doi.org\/10.1054\/jocn.1999.0194","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}